Veterinary Medicines

Tabic VH

Authorised
  • Newcastle disease virus, strain V.H., Live
Download as PDF

Product identification

Medicine name:
Tabic VH
Active substance:
  • Newcastle disease virus, strain V.H., Live
Target species:
  • Chicken
  • Chicken (one day-old chick)
  • Chicken (for reproduction)
Route of administration:
  • Buccal use
  • Inhalation use
  • Ocular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain V.H., Live
    1000000.00
    50% Embryo Infective Dose
    /
    1.00
    Tablet
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Buccal use
    • Chicken
      • Meat and offal
        0
        day
  • Inhalation use
    • Chicken (one day-old chick)
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
  • Ocular use
    • Chicken (one day-old chick)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Abic Polska Sp. z o.o.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 200163
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 20/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."